INNOVATE BIOPHARMACEUTICALS, INC. Note Agreements
10 Contracts & Agreements
- First Amendment to the Amended and Restated Senior Secured Convertible Note Due 2025 (Filed With SEC on January 13, 2023)
- Form of Amended and Restated Senior Secured Convertible Note (Filed With SEC on November 8, 2022)
- Form of Senior Secured Convertible Note (Filed With SEC on June 30, 2022)
- Note Purchase Agreement, dated January 10, 2020, by and between the Company and Atlas Sciences, LLC (Filed With SEC on January 10, 2020)
- Note issued to Atlas Sciences, LLC (Filed With SEC on January 10, 2020)
- Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC (Filed With SEC on March 13, 2019)
- Note issued to Atlas Sciences, LLC (Filed With SEC on March 13, 2019)
- Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019 (Filed With SEC on January 11, 2019)
- Senior Convertible Note with Gustavia Capital Partners LLC (Filed With SEC on October 5, 2018)
- Senior Note dated January 29, 2018 (Filed With SEC on February 2, 2018)